Central composite design–based optimization, fabrication, and pharmacodynamic assessment of sulfasalazine-loaded lipoidal nanoparticle-based hydrogel for the management of rheumatoid arthritis
暂无分享,去创建一个
[1] I. Kaur,et al. In vitro release, ex vivo penetration, and in vivo dermatokinetics of ketoconazole-loaded solid lipid nanoparticles for topical delivery , 2022, Drug Delivery and Translational Research.
[2] N. Verma,et al. Investigating nanostructured liquid crystalline particles as prospective ocular delivery vehicle for tobramycin sulfate: Ex vivo and in vivo studies , 2021, Journal of Advanced Pharmaceutical Technology & Research.
[3] Siti Khadijah Adam,et al. Central Composite Design for Formulation and Optimization of Solid Lipid Nanoparticles to Enhance Oral Bioavailability of Acyclovir , 2021, Molecules.
[4] A. Almeida,et al. Increased Therapeutic Efficacy of SLN Containing Etofenamate and Ibuprofen in Topical Treatment of Inflammation , 2021, Pharmaceutics.
[5] Y. Shin,et al. Quantification and Metabolite Identification of Sulfasalazine in Mouse Brain and Plasma Using Quadrupole-Time-of-Flight Mass Spectrometry , 2021, Molecules.
[6] Upendra Nagaich,et al. Colon Targeted Protein Nanoparticles Loaded Suppositories : Effective against Intestinal Parasites , 2020, Advanced pharmaceutical bulletin.
[7] M. Koland,et al. Topical Delivery of Fenugreek Seed Extract Loaded Solid Lipid Nanoparticles Based Hydrogels for Alopecia , 2021, Journal of Pharmaceutical Research International.
[8] Suman Jain,et al. Development of nitazoxanide-loaded colon-targeted formulation for intestinal parasitic infections: centre composite design-based optimization and characterization , 2020, Future Journal of Pharmaceutical Sciences.
[9] A. Dhar,et al. A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems , 2020, RSC advances.
[10] C. Patra,et al. Lyophilized SLN of Cinnacalcet HCl: BBD enabled optimization, characterization and pharmacokinetic study , 2020, Drug development and industrial pharmacy.
[11] Venkateshwaran Krishnaswami,et al. Correction to: Development of Methotrexate and Minocycline Loaded Nanoparticles for the Effective Treatment of Rheumatoid Arthritis , 2020, AAPS PharmSciTech.
[12] R. Sarkar,et al. Sulfasalazine in dermatology: A lesser explored drug with broad therapeutic potential , 2020, International journal of women's dermatology.
[13] Venkateshwaran Krishnaswami,et al. Development of Methotrexate and Minocycline-Loaded Nanoparticles for the Effective Treatment of Rheumatoid Arthritis , 2019, AAPS PharmSciTech.
[14] Venkateshwaran Krishnaswami,et al. Development of methotrexate-loaded cubosomes with improved skin permeation for the topical treatment of rheumatoid arthritis , 2019, Applied Nanoscience.
[15] M. Deka,et al. Combinatorial therapeutic approach for treatment of oral squamous cell carcinoma , 2019, Artificial cells, nanomedicine, and biotechnology.
[16] M. Anwer,et al. Development and optimization of erythromycin-loaded lipid-based gel by Taguchi design: In vitro characterization and antimicrobial evaluation , 2019, Brazilian Journal of Pharmaceutical Sciences.
[17] S. Shen,et al. Effect of magnetic nanoparticles size on rheumatoid arthritis targeting and photothermal therapy. , 2018, Colloids and surfaces. B, Biointerfaces.
[18] Leonardo Fernandes Fraceto,et al. Nano based drug delivery systems: recent developments and future prospects , 2018, Journal of Nanobiotechnology.
[19] A. Saleh,et al. Rheumatoid Arthritis: A Brief Overview of the Treatment , 2018, Medical Principles and Practice.
[20] Bhupinder Singh,et al. Preclinical Explorative Assessment of Celecoxib-Based Biocompatible Lipidic Nanocarriers for the Management of CFA-Induced Rheumatoid Arthritis in Wistar Rats , 2018, AAPS PharmSciTech.
[21] Bhupinder Singh,et al. Preclinical Explorative Assessment of Celecoxib-Based Biocompatible Lipidic Nanocarriers for the Management of CFA-Induced Rheumatoid Arthritis in Wistar Rats , 2018, AAPS PharmSciTech.
[22] V. Garg,et al. A Novel Three-pronged Approach for Colon Delivery of Sulfasalazine: Concomitant Use of pH- Responsive, Microbially Triggered Polymers and Liquisolid Technology. , 2018, Current Drug Delivery.
[23] Upendra Nagaich,et al. Preclinical Assessment of Steroidal Nanostructured Lipid Carriers Based Gels for Atopic Dermatitis: Optimization and Product Development. , 2018, Current Drug Delivery.
[24] Upendra Nagaich,et al. Fabrication and evaluation of ultra deformable vesicles for atopic dermatitis as topical delivery , 2018 .
[25] Seyedeh Sara Esnaashari,et al. Investigation of Effective Parameters on Size of Paclitaxel Loaded PLGA Nanoparticles , 2018, Advanced pharmaceutical bulletin.
[26] F. Shabani,et al. Central Composite Design Optimization of Zinc Removal from Contaminated Soil, Using Citric Acid as Biodegradable Chelant , 2018, Scientific Reports.
[27] Zhirong Zhong,et al. Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy , 2018, Drug delivery.
[28] S. K. Singh,et al. Review of Nanoemulsion Formulation and Characterization Techniques , 2018 .
[29] V. Londhe,et al. Zaltoprofen loaded solid lipid nanoparticles for topical delivery: formulation design, In vitro and Ex vivo evaluation , 2017 .
[30] G. Patel,et al. FORMULATION OPTIMIZATION AND CHARACTERIZATION OF GANCICLOVIR LOADED DRY CHITOSAN NANOPARTICLES , 2017 .
[31] A. Madgulkar,et al. Formulation of piperine solid lipid nanoparticles (SLN) for treatment of rheumatoid arthritis , 2017, Drug development and industrial pharmacy.
[32] Y. Mehmood,et al. Application of UV spectrophotometric method for easy and rapid estimation of sulfasalazine in pharmaceutical formulation (suspension) , 2017 .
[33] N. Mondal,et al. Optimisation using central composite design (CCD) and the desirability function for sorption of methylene blue from aqueous solution onto Lemna major , 2016 .
[34] Upendra Nagaich,et al. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization , 2016, Drug Delivery and Translational Research.
[35] N. Picci,et al. Preparation, characterization and in vitro activities evaluation of solid lipid nanoparticles based on PEG-40 stearate for antifungal drugs vaginal delivery , 2016, Drug delivery.
[36] Sacheen Kumar,et al. Solid lipid nanoparticles of stearic acid for the drug delivery of paliperidone , 2015 .
[37] Upendra Nagaich,et al. Fabrication and in vitro characterization of polymeric nanoparticles for Parkinson's therapy: a novel approach , 2014 .
[38] S. Saraf,et al. Green Nanoparticle Strategies: Utilizing Excipients Sourced from Nature , 2014 .
[39] P. R. Vuddanda,et al. Development and Evaluation of Solid Lipid Nanoparticles of Raloxifene Hydrochloride for Enhanced Bioavailability , 2013, BioMed research international.
[40] Upendra Nagaich,et al. Intranasal Delivery of Chitosan Nanoparticles for Migraine Therapy , 2013, Scientia pharmaceutica.
[41] D. Mcclements,et al. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). , 2009, Journal of colloid and interface science.
[42] Y. Choi,et al. Formulation of microemulsion systems for transdermal delivery of aceclofenac , 2005, Archives of pharmacal research.
[43] G. Plosker,et al. Sulfasalazine , 2012, Drugs.
[44] Changsheng Xie,et al. Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain. , 2004, Biomaterials.
[45] L. Brannon-Peppas. Book reviewHandbook of pharmaceutical excipients: A. Wade and P.J. Weller (Eds.), 2nd Edn., 1994, American Pharmaceutical Association, Washington and The Pharmaceutical Press, London, 651 pages, £140.00 , 1996 .